Cargando…

Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer

Trastuzumab, a humanized mouse monoclonal antibody directed against HER2 (Human Epidermal Growth Factor Receptor 2), is currently a keystone in the treatment of breast cancer. Meanwhile, trastuzumab has been validated for use in other types of cancer too. But the data on HER2 expression in colorecta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blok, Erik J, Kuppen, Peter JK, van Leeuwen, Jeroen EM, Sier, Cornelis FM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583442/ https://www.ncbi.nlm.nih.gov/pubmed/23471238 http://dx.doi.org/10.4137/CMO.S10811

Ejemplares similares

Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study
por: Boonstra, Martin C, et al.
Publicado: (2014)

A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer
por: Krijgsman, Daniëlle, et al.
Publicado: (2019)

Biomarkers in precision therapy in colorectal cancer
por: Reimers, Marlies S., et al.
Publicado: (2013)

Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins
por: Boonstra, Martin C., et al.
Publicado: (2016)

Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells
por: de Geus, Susanna WL, et al.
Publicado: (2017)

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
por: Kavanagh, Dara O, et al.
Publicado: (2009)

The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
por: Engels, Charla C., et al.
Publicado: (2016)

Overexpression of ICAT Inhibits the Progression of Colorectal Cancer by Binding with β-Catenin in the Cytoplasm
por: Hu, Jiancong, et al.
Publicado: (2021)

The CpG island methylator phenotype (CIMP) in colorectal cancer
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2013)

KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
por: Bar, Julia K, et al.
Publicado: (2012)

Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer
por: Blok, Erik J., et al.
Publicado: (2017)

Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients
por: Speetjens, Frank M., et al.
Publicado: (2008)

The Prognostic Value of the Apoptosis Pathway in Colorectal Cancer: A Review of the Literature on Biomarkers Identified by Immunohistochemistry
por: Zeestraten, Eliane C.M., et al.
Publicado: (2013)

HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer
por: Luo, Hai, et al.
Publicado: (2021)

uPAR directed-imaging of head-and-neck cancer
por: Baart,, Victor M., et al.
Publicado: (2017)

uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery
por: Boonstra, Martin C., et al.
Publicado: (2015)

Stromal Targets for Fluorescent-Guided Oncologic Surgery
por: Boonstra, Martin C., et al.
Publicado: (2015)

Clinical implications of BRAF mutation test in colorectal cancer
por: Mojarad, Ehsan Nazemalhosseini, et al.
Publicado: (2013)

Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery
por: Stammes, Marieke A., et al.
Publicado: (2017)

Overexpression of HER2/HER3 and clinical feature of ovarian cancer
por: Chung, Ye Won, et al.
Publicado: (2019)

Obesity and HER 2 overexpression: a common factor for poor prognosis of breast cancer
por: Sellahewa, Chaminda, et al.
Publicado: (2008)

In Search for Optimal Targets for Intraoperative Fluorescence Imaging of Peritoneal Metastasis From Colorectal Cancer
por: Hoogstins, Charlotte ES, et al.
Publicado: (2017)

Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis
por: Yan, Qingying, et al.
Publicado: (2018)

MicroRNA and HER2-overexpressing Cancer
por: Wang, Shizhen Emily, et al.
Publicado: (2013)

Towards comprehensive characterization of HER2 overexpression
por: Berezov, Alan, et al.
Publicado: (2006)

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
por: Pinhel, Isabel, et al.
Publicado: (2012)

Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma
por: Bosma, Sarah E, et al.
Publicado: (2018)

Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway
por: Ohtsuka, Tomoaki, et al.
Publicado: (2016)

The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers
por: Lemieux, J., et al.
Publicado: (2009)

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
por: Horimoto, Yoshiya, et al.
Publicado: (2022)

Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
por: Reimers, Marlies S, et al.
Publicado: (2014)

Suspicion Is Key: Diagnosing Elusive Cytoplasmic Antineutrophil Cytoplasmic Antibody (c-ANCA)-Positive Vasculitis
por: Crowe, Timothy P, et al.
Publicado: (2022)

MHC class I expression protects rat colon carcinoma cells from hepatic natural killer cell-mediated apoptosis and cytolysis, by blocking the perforin/granzyme pathway
por: Luo, Dianzhong, et al.
Publicado: (2002)

CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy
por: Linders, Daan, et al.
Publicado: (2021)

The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer
por: Dent, S., et al.
Publicado: (2009)

Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer
por: de Muijnck, Cansu, et al.
Publicado: (2020)

Algorithms for the quantitative Lock/Key model of cytoplasmic incompatibility
por: Calamoneri, Tiziana, et al.
Publicado: (2020)

Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo
por: Guan, Siao-Syun, et al.
Publicado: (2014)

Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis
por: Wu, Sheng-wen, et al.
Publicado: (2015)

HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients
por: Abdul Razzaq, Eman A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_idjt9qokcgm8p2kblb8pgfrr1v